genuine acupuncture sessions may have been the result of an order effect. This explanation, however, cannot be used to explain any of the demonstrated superiority of genuine acupuncture over pseudoacupuncture since these sessions were in balanced order of presentation.
Introduction
Fenfluramine hydrochloride has an antiobesity and anorectic action and has been successfully used to treat obesity.' 2 It is chemically similar to amphetamine but lacks its central stimulant effects.3 Several studies have shown that the cate-cholamines are intimately concerned in the sleep mechanism4-6 and that the anorectic action of fenfluramine depends on a direct or indirect serotonin mechanism.7 Moreover, the antiobesity action of fenfluramine may be related to its specific ascorbic acid releasing action,8 9 while dietary desaturation of ascorbic acid potentiates the antiobesity action of fenfluramine in man.'0 Administration of vitamin C 2000 mg/day produces better nocturnal sleep and less sleeplessness in young adults than placebo treatment." We investigated the effect of fenfluramine on the dream pattern of 20 patients who were receiving a weight-reducing diet and either fenfluramine or placebo tablets.
Subjects and methods
Eighteen women and two men participated. The investigation was part of a larger trial in which the effect of ascorbic acid was examined on the antiobesity action of fenfluramine."0 The patients were aged 14-63 years (mean 43 years). Each patient received a 4 18-MJ (1000 kcal) reducing diet. Alternate patients received either a controlled intake of 40 mg vitamin C daily, or a diet free of vitamin C. All received fenfluramine in daily doses ranging from 20 to 80 mg/ day. The patients completed a daily chart of their weight, sleep and dream pattern, and mood. They were asked to record the number and nature of their dreams each morning on waking.
Placebo tablets were administered double blind to four of the patients for four weeks from the 10th week of the investigation. Some patients received tablets for as long as 17 weeks (see table) .
Results
Of the 20 patients, five received other forms of drug treatment consisting of ketoprufen, indomethacin, amitryptyline, or reserpine. None of these patients experienced any change in the nature or increase in the frequency of their dreams while receiving fenfluramine. table) .
None of the remaining 13 patients received any drugs other than fenfluramine or vitamin C. These 13 patients experienced a change in the pattern of their dreaming as the dose of fenfluramine was increased.
Seven of them received a controlled intake of 40 mg vitamin C daily, and six received no vitamin C in their 4 18-MJ diet. There was no significant difference in the dream pattern between these two groups. Seven reported an increase in dream frequency with the smallest dose of fenfluramine (20 mg fenfluramine for four weeks. After two nights their dreaming habits returned to the pretreatment pattern in that dreams became much less frequent and vivid. This change was maintained throughout the placebo period. When fenfluramine was resumed at the end of four weeks the dreams rapidly resumed their former frequency and intensity under the influence of the drug (see table) .
The responses to each dose-of fenfluramine were analysed on the IBM 360/44 computer. A regression line was obtained showing response in dream nights per week against the dose of fenfluramine administered in mg day (see figure) . The data were transformed by arcuate transformation to stabilise variance, and an F test performed on the regression, showed that it was highly significant (P < 0 0001).
There was no statistical evidence of deviation from a straight line relation, and the intercept of the line was not significantly different from zero. The apparent lack of fit of the regression line to the raw data may have been due partly to the deviation of the data from a symmetrical distribution at some dose levels.
Discussion
Alvil' has reported that an evening dose of fenfluramine led to complaints of nightmares on several succeeding nights, and 
Summary
In a prospective study of 196 consecutive single births a significant increase in serum bilirubin concentrations was found in infants born after low amniotomy induction and oxytocin infusion compared with those born spontaneously. This relationship was not dose-dependent and may have been associated with artificial interruption of pregnancy rather than the oxytocin itself. Infants delivered after spontaneous labour accelerated by oxytocin showed no such increase. The hormonal surge at the spontaneous onset of labour may affect fetal enzyme induction, but other factors, such as methods of infant feeding and oral contraceptive use, were found not to be significant.-
Introduction
The use of oxytocin infusion to induce labour is now routine in many centres. Simultaneous surgical and medical induction has been advocated,' 2 and the interval between induction and delivery has been reduced to about eight hours.3 Hazards of these procedures, however, include fetal distress and low Apgar scores.5 Oxytocin has been implicated in an increased incidence of neonatal jaundice,6-8 though other workers have failed to confirm this. [9] [10] [11] We have carried out a prospective study of the factors implicated in neonatal jaundice and report here the results.
Patients and methods
A total of 217 consecutive single deliveries at this hospital were considered for the study. Of these, 21 babies were excluded because of incomplete bilirubin data, birth weight below 2500 g, haemolytic disease, neonatal infection, or discharge from hospital within 48 hours. A further 15 infants were delivered by caesarean section. The remaining 181 babies were divided into three groups: A (54 infants), spontaneous onset of labour, no oxytocin used; B (28 infants), spontaneous onset of labour, oxytocin used to accelerate labour; C (99 infants),
